Literature DB >> 27692535

Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer.

A Larcher1, M Sun2, P Dell'Oglio3, V Trudeau4, K Boehm5, J Schiffmann5, Z Tian6, N Fossati7, U Capitanio8, A Briganti8, F Montorsi8, P Karakiewicz4.   

Abstract

BACKGROUND: Local tumour ablation (LTA) may yield better perioperative outcomes than partial nephrectomy (PN), however the impact of each treatment on perioperative mortality and health care expenditures is unknown. The aim of the study was to compare mortality, morbidity and health care expenditures between LTA and PN. PATIENTS AND METHODS: A population-based assessment of 2471 patients with cT1a kidney cancer treated with either LTA or PN, between 2000 and 2009, in the SEER-Medicare database was performed. After propensity score matching, 30-day mortality, overall and specific complication rates, length of stay, readmission rates and health care expenditures according to LTA or PN were estimated. Multivariable logistic and linear models addressed the effect of each specific LTA approach on overall complication rates, length of stay, readmission rates and health care expenditures.
RESULTS: The 30-day mortality was <2% after either LTA or PN (OR 2.27, p = 0.2). The overall complication rate was 21% after LTA and 40% after PN (OR 0.38, p < 0.001). Blood transfusions, infection/sepsis, wound infections, respiratory complications, gastrointestinal complications, acute kidney injury, and accidental puncture or laceration/foreign body left during procedure rates resulted lower after LTA relative to PN (all p < 0.05). Similarly, length of stay and health care expenditures resulted lower after LTA relative to PN (all p < 0.05). Conversely, readmission rate was not significantly different in LTA relative to PN (p = 0.1).
CONCLUSIONS: Despite similar perioperative mortality, LTA is associated with lower complications rate, shorter length of stay and lower health care expenditure relative to PN.
Copyright © 2016 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Complications; Health care expenditure; Kidney cancer; Local tumour ablation; Nephron sparing surgery; Partial nephrectomy; Perioperative mortality

Mesh:

Year:  2016        PMID: 27692535     DOI: 10.1016/j.ejso.2016.08.023

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

1.  Acute kidney injury after partial nephrectomy: transient or permanent kidney damage?-Impact on long-term renal function.

Authors:  Giuseppe Rosiello; Umberto Capitanio; Alessandro Larcher
Journal:  Ann Transl Med       Date:  2019-12

2.  Renal Thermal Ablation Trends of American Urologists.

Authors:  Wei Phin Tan; Ariel A Schulman; Gregory J Barton; Christina Sze; Thomas J Polascik
Journal:  J Endourol       Date:  2020-01-22       Impact factor: 2.942

Review 3.  Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review.

Authors:  Chun-Ru Chien; Daniel M Geynisman; Bumyang Kim; Ying Xu; Ya-Chen Tina Shih
Journal:  Pharmacoeconomics       Date:  2019-03       Impact factor: 4.981

Review 4.  Systematic Review of Contemporary Evidence for the Management of T1 Renal Cell Carcinoma: What IRs Need to Know for Kidney Cancer Tumor Boards.

Authors:  Julie Cronan; Sean Dariushnia; Zachary Bercu; Robert Mitchell Ermentrout; Bill Majdalany; Laura Findeiss; Janice Newsome; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

Review 5.  [Ablative therapy of small renal masses].

Authors:  M C Kriegmair; N Wagener; S J Diehl; N Rathmann
Journal:  Urologe A       Date:  2018-03       Impact factor: 0.639

Review 6.  Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence.

Authors:  Shamar Young; Jafar Golzarian; J Kyle Anderson
Journal:  Semin Intervent Radiol       Date:  2019-12-02       Impact factor: 1.513

7.  Survival benefit of nephron-sparing surgery for patients with pT1b renal cell carcinoma: A population-based study.

Authors:  Xiaode Liu; Xuemei Huang; Pan Zhao; Peng Zhang
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

Review 8.  Applications of Focused Ultrasound in the Treatment of Genitourinary Cancers.

Authors:  John Panzone; Timothy Byler; Gennady Bratslavsky; Hanan Goldberg
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.